{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:11:10Z","timestamp":1787962270222,"version":"build-2784847793"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2000,6,1]],"date-time":"2000-06-01T00:00:00Z","timestamp":959817600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2000,6]]},"DOI":"10.1136\/ard.59.6.468","type":"journal-article","created":{"date-parts":[[2002,7,27]],"date-time":"2002-07-27T10:45:32Z","timestamp":1027766732000},"page":"468-477","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial"],"prefix":"10.1016","volume":"59","author":[{"given":"C H M","family":"van Jaarsveld","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J W G","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"van der Veen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A A M","family":"Blaauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A A","family":"Kruize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D M","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H L M","family":"Brus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G A","family":"van Albada-Kuipers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A H M","family":"Heurkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E J","family":"ter Borg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H C M","family":"Haanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"van Booma-Frankfort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Schenk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J W J","family":"Bijlsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/ard.59.6.468_bib1","first-page":"1408","article-title":"Rethinking rheumatic disease therapy.","volume":"16","author":"Roth","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.59.6.468_bib2","first-page":"4","article-title":"Challenging the therapeutic pyramid: a new look at treatment strategies for rheumatoid arthritis.","volume":"17","author":"Wilske","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.59.6.468_bib3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7326\/0003-4819-124-8-199604150-00001","article-title":"The effectiveness of early treatment with \u201csecond-line\u201d antirheumatic drugs: a randomized, controlled trial.","volume":"124","author":"van der Heide","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.59.6.468_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1136\/ard.48.5.389","article-title":"A double blind comparative study of sulphasalazine and hydroxychloroquine in rheumatoid arthritis: evidence of an earlier effect of sulphasalazine.","volume":"48","author":"Nuver-Zwart","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.59.6.468_bib5","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/rheumatology\/36.8.870","article-title":"Auranofin is safe and superior to placebo in elderly-onset rheumatoid arthritis.","volume":"36","author":"Glennas","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.59.6.468_bib6","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/art.1780331001","article-title":"The comparative efficacy and toxicity of second-line drugs in rheumatoid arthritis - results of two meta-analyses.","volume":"33","author":"Felson","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.6.468_bib7","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1093\/rheumatology\/35.11.1154","article-title":"Injectable gold compounds: an overview.","volume":"35","author":"Jones","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.59.6.468_bib8","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/rheumatology\/36.3.345","article-title":"Comparison of intramuscular methotrexate and gold sodium thiomalate in the treatment of early erosive rheumatoid arthritis: 12 month data of a double-blind parallel study of 174 patients.","volume":"36","author":"Rau","year":"1997","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.59.6.468_bib9","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1136\/ard.46.3.177","article-title":"Long term treatment of rheumatoid arthritis with sulphasalazine, gold, or penicillamine: a comparison using life-table methods.","volume":"46","author":"Situnayake","year":"1987","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.59.6.468_bib10","first-page":"914","article-title":"Short term effects of low dose methotrexate on the acute phase reaction in patients with rheumatoid arthritis.","volume":"16","author":"Segal","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.59.6.468_bib11","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/03009748709096720","article-title":"Long term experience of salazopyrin EN in rheumatoid arthritis (RA).","volume":"64","author":"Farr","year":"1987","journal-title":"Scand J Rheumatol"},{"key":"10.1136\/ard.59.6.468_bib12","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.6.468_bib13","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1136\/ard.48.3.256","article-title":"What should we achieve when treating rheumatoid arthritis?","volume":"48","author":"Scott","year":"1989","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.59.6.468_bib14","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/0049-0172(92)90022-6","article-title":"The impact of endpoint measures in rheumatoid arthritis clinical trials.","volume":"21","author":"van der Heide","year":"1992","journal-title":"Semin Arthritis Rheum"},{"key":"10.1136\/ard.59.6.468_bib15","first-page":"71","article-title":"Development and validation of the Dutch questionnaire capacities of daily life (VDF) for patients with rheumatoid arthritis.","volume":"3","author":"Bijlsma","year":"1990","journal-title":"Journal of Rehabilitation Sciences"},{"key":"10.1136\/ard.59.6.468_bib16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1136\/ard.52.7.497","article-title":"Self report functional disability scores and the use of devices: two distinct aspects of physical function in rheumatoid arthritis.","volume":"52","author":"van der Heide","year":"1993","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/ard.59.6.468_bib17","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/art.1780300603","article-title":"Articular indices for joint inflammation with rheumatoid arthritis. Correlation with the acute-phase response.","volume":"30","author":"Thompson","year":"1987","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.6.468_bib18","first-page":"28","article-title":"Evaluation of the Thompson articular index.","volume":"20","author":"van den Brink","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.59.6.468_bib19","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1002\/art.1780281203","article-title":"How many hands and wrists should be included in a score of radiologic abnormalities used to assess rheumatoid arthritis?","volume":"28","author":"Sharp","year":"1985","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.6.468_bib20","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(89)92442-2","article-title":"Effects of hydroxychloroquine and sulphasalazine on progression of joint damage in rheumatoid arthritis.","volume":"i","author":"van der Heijde","year":"1989","journal-title":"Lancet"},{"key":"10.1136\/ard.59.6.468_bib21","first-page":"561","article-title":"Criteria for clinically important changes in outcomes: development, scoring and evaluation of rheumatoid arthritis patient and trial profiles.","volume":"20","author":"Goldsmith","year":"1993","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.59.6.468_bib22","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1002\/art.1780380602","article-title":"American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis.","volume":"38","author":"Felson","year":"1995","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.6.468_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/art.1780330403","article-title":"Analysis of improvement in individual rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs, based on the findings in patients treated with placebo.","volume":"33","author":"Paulus","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.6.468_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons.","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology"},{"key":"10.1136\/ard.59.6.468_bib25","series-title":"SPSS 6.1 advantaged statistics user\u2019s guide.","author":"Norusis","year":"1990"},{"key":"10.1136\/ard.59.6.468_bib26","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions.","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1136\/ard.59.6.468_bib27","first-page":"S271","article-title":"Toxicity of anti-rheumatic drugs in a randomized clinical trial of early rheumatoid arthritis [abstract].","volume":"41(suppl)","author":"van Jaarsveld","year":"1998","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.6.468_bib28","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/rheumatology\/37.5.555","article-title":"National database of patients visiting rheumatologists in the Netherlands: the standard diagnosis register of rheumatic diseases. A report and preliminary analysis.","volume":"37","author":"Miedema","year":"1998","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.59.6.468_bib29","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/art.1780390503","article-title":"Guidelines for monitoring drug therapy in rheumatoid arthritis.","volume":"39","year":"1996","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.6.468_bib30","series-title":"Clinical epidemiology - the essentials.","author":"Fletcher","year":"1988"},{"key":"10.1136\/ard.59.6.468_bib31","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0021-9681(67)90041-0","article-title":"Explanatory and pragmatic attitudes in therapeutical trials.","volume":"20","author":"Schwartz","year":"1967","journal-title":"J Chron Dis"},{"key":"10.1136\/ard.59.6.468_bib32","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.7326\/0003-4819-119-11-199312010-00002","article-title":"Hydroxychloroquine compared with placebo in rheumatoid arthritis. A randomized controlled trial.","volume":"119","author":"Clark","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1136\/ard.59.6.468_bib33","first-page":"163","article-title":"Parenteral methotrexate or gold for rheumatoid arthritis: a follow up.","volume":"8","author":"Suarez-Almazor","year":"1990","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.59.6.468_bib34","first-page":"1268","article-title":"Clinical and laboratory effects of prolonged therapy with sulfasalazine, gold or penicillamine: the effects of disease duration on treatment response.","volume":"17","author":"Situnayake","year":"1990","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.59.6.468_bib35","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2125.1996.04038.x","article-title":"Combination of methotrexate and sulphasalazine in patients with rheumatoid arthritis: pharmacokinetic analysis and relationship to clinical response.","volume":"42","author":"Haagsma","year":"1996","journal-title":"Br J Clin Pharmacol"},{"key":"10.1136\/ard.59.6.468_bib36","first-page":"1797","article-title":"Radiographic progression in rheumatoid arthritis: results of 3 comparative trials.","volume":"22","author":"van Riel","year":"1995","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.59.6.468_bib37","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1002\/art.1780361006","article-title":"Radiographic assessment of disease progression in rheumatoid arthritis patients enrolled in the cooperative systematic studies of the rheumatic diseases program randomized clinical trial of methotrexate, auranofin, or a combination of the two.","volume":"36","author":"Lopez Mendez","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.6.468_bib38","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/art.1780360507","article-title":"The effects of drug therapy on radiographic progression of rheumatoid arthritis. Results of a 36-week randomized trial comparing methotrexate and auranofin.","volume":"36","author":"Weinblatt","year":"1993","journal-title":"Arthritis Rheum"},{"key":"10.1136\/ard.59.6.468_bib39","first-page":"263","article-title":"Influence of methotrexate on radiographic progression in rheumatoid arthritis: a sixty-month prospective study.","volume":"15","author":"Drosos","year":"1997","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.59.6.468_bib40","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/rheumatology\/35.11.1096","article-title":"Natural remission in inflammatory polyarthritis: issues of definition and prediction.","volume":"35","author":"Harrison","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.59.6.468_bib41","first-page":"625","article-title":"D-penicillamine in early rheumatoid arthritis: experience from a 2-year double blind placebo controlled study.","volume":"14","author":"Eberhardt","year":"1996","journal-title":"Clin Exp Rheumatol"},{"key":"10.1136\/ard.59.6.468_bib42","first-page":"328","article-title":"A double blind randomized parallel trial of intramuscular methotrexate and gold sodium thiomalate in early erosive rheumatoid arthritis.","volume":"18","author":"Rau","year":"1991","journal-title":"J Rheumatol"},{"key":"10.1136\/ard.59.6.468_bib43","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/rheumatology\/35.11.1101","article-title":"Remission in a prospective study of patients with rheumatoid arthritis. American Rheumatism Association preliminary remission criteria in relation to the disease activity score.","volume":"35","author":"Prevoo","year":"1996","journal-title":"Br J Rheumatol"},{"key":"10.1136\/ard.59.6.468_bib44","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0140-6736(97)01300-7","article-title":"Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis.","volume":"350","author":"Boers","year":"1997","journal-title":"Lancet"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724381993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724381993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/ard.59.6.468","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T04:52:09Z","timestamp":1737262329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724381993"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,6]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2000,6]]}},"alternative-id":["S0003496724381993"],"URL":"https:\/\/doi.org\/10.1136\/ard.59.6.468","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2000,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aggressive treatment in early rheumatoid arthritis: a randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/ard.59.6.468","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2000 Annals of the Rheumatic Diseases, Published by Elsevier Inc. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}